New York, NY, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQ) (the “Company”), announced contiguous that an aggregate of $1,265,000 has been deposited into the Company’s spot relationship for its nationalist shareholders, representing $0.10 per nationalist share, which enables the Company to widen the play of clip it has to consummate its archetypal concern operation by 3 months from October 29, 2022 to January 29, 2023 (the “Extension”). The Extension is the archetypal of up to 2 three-month extensions permitted nether the Company’s governing documents.
About Deep Medicine Acquisition Corp.
DMAQ is simply a peculiar intent acquisition institution formed for the intent of entering into a merger, superior banal exchange, plus acquisition, banal purchase, reorganization oregon different akin concern operation with 1 oregon much businesses oregon entities. DMAQ began trading connected the Nasdaq successful October 2021, and its communal banal and rights are traded nether the ticker symbols DMAQ and DMAQR, respectively.
Cautionary Note Regarding Forward-Looking Statements
This property merchandise whitethorn include, and oral statements made from clip to clip by representatives of the Company whitethorn include, “forward-looking statements” wrong the meaning of Section 27A of the Securities Act of 1933, arsenic amended, and Section 21E of the Securities Exchange Act of 1934, arsenic amended. Statements regarding imaginable concern combinations and the financing thereof, and related matters, arsenic good arsenic each different statements different than statements of humanities information included successful this property merchandise are forward-looking statements. When utilized successful this property release, words specified arsenic “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and akin expressions, arsenic they subordinate to america oregon our absorption team, place forward-looking statements. Such forward-looking statements are based connected the beliefs of management, arsenic good arsenic assumptions made by, and accusation presently disposable to, the Company’s management. Actual results could disagree materially from those contemplated by the forward-looking statements arsenic a effect of definite factors elaborate successful the Company’s filings with the Securities and Exchange Commission (“SEC”). All consequent written oregon oral forward-looking statements attributable to america oregon persons acting connected our behalf are qualified successful their entirety by this paragraph. Forward-looking statements are taxable to galore conditions, galore of which are beyond the power of the Company, including those acceptable distant successful the Risk Factors conception of the Company’s registration connection and prospectus for the Company’s archetypal nationalist offering filed with the SEC. The Company undertakes nary work to update these statements for revisions oregon changes aft the day of this release, but arsenic required by law.
Contact
Humphrey Polanen, Chief Executive Officer
Deep Medicine Acquisition Corp.
595 Madison Avenue, 12th Floor
New York, NY 10017
ir@dmaq-spac.com
Telephone: (917) 289-2776
English (US)